Novel oral anticoagulants in intracardiac thrombosis resolution: a case series

BACKGROUND: Vitamin K antagonists (VKAs) have been regarded as the therapy of choice for intracardiac thrombosis for decades based mostly on observational data. The advent of direct oral anticoagulants (DOACs) has displaced VKAs as the first-line therapy for multiple thrombotic disorders but not for...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sadawi, Mohammed, Francois, Jonathan, Rodriguez Ortega, Romy, Capric, Violeta, Budzikowski, Adam S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649461/
https://www.ncbi.nlm.nih.gov/pubmed/33204959
http://dx.doi.org/10.1093/ehjcr/ytaa181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649461/
https://www.ncbi.nlm.nih.gov/pubmed/33204959
http://dx.doi.org/10.1093/ehjcr/ytaa181

Ejemplares similares